{"version":"1.0","type":"link","title":"PREDICT v3.0 outperforms v2.2 in young (25-40 years) breast cancer patients according to real-world data from a large Swedish population-based registry.","author_name":"Lundgren C 외","author_url":"https://prs-insight.online/author/Lundgren%20C","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/79356","thumbnail_width":1200,"thumbnail_height":630}